HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men
- 10 September 2020
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 136 (11), 1359-1367
- https://doi.org/10.1182/blood.2020007003
Abstract
In 2015, the FDA published revised guidance that recommended a change in blood donor deferral of men who have sex with men (MSM) from an indefinite to a 12-month deferral since last sex. We assessed whether HIV incidence or associated transfusion risk increased in first-time blood donors. Donations in four major blood collection organizations were monitored for 15 months before and two years after implementation of the 12-month MSM deferral policy. HIV-positive donations were classified as recently acquired or long-term using a recent infection testing algorithm and incidence in both periods estimated. Residual transfusion-transmission risk was estimated by multiplying incidence with the infectious pre-NAT window period, estimated using a model based on infectious dose and the screening algorithm's sensitivity. Factors associated with incident infection in each period were assessed using Poisson Regression. Overall HIV incidence in first-time donors before implementation of the 12-month MSM deferral was estimated at 2.62/105 person-years (95% CI: 1.53,3.93), and after implementation at 2.85 (95% CI: 1.96,3.93), with no statistically significant change. In male first-time donors the incidence difference was 0.93 (95% CI: -1.74,3.58). The residual risk of HIV transfusion transmission per 106 transfusions of packed red blood cell components sourced from first-time donors was estimated at 0.32 (95% CI: 0.29,0.65) before, and 0.35 (95% CI: 0.31,0.65) after implementation, with the difference not significant. Factors associated with incident infection were the same in each period. We observed no increase in HIV incidence or HIV transfusion transmission risk after implementation of a 12-month MSM deferral policy.This publication has 23 references indexed in Scilit:
- Transfusion‐transmissible infection monitoring system: a tool to monitor changes in blood safetyTransfusion, 2016
- Modeling complete removal of risk assessment questions in the USA predicts the risk of HIV exposure in blood recipients could increase despite the use of nucleic acid testingVox Sanguinis, 2016
- Prevalence of human immunodeficiency virus RNA and antibody in first‐time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenariosTransfusion, 2013
- A New General Biomarker-based Incidence EstimatorEpidemiology, 2012
- Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysisThe Lancet, 2012
- Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic DonationsTransfusion Medicine Reviews, 2012
- Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithmsTransfusion, 2010
- Development of Two Avidity-Based Assays to Detect Recent HIV Type 1 Seroconversion Using a Multisubtype gp41 Recombinant ProteinAIDS Research and Human Retroviruses, 2010
- Patterns of age‐ and sex‐specific prevalence of major blood‐borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor studyTransfusion, 2004
- Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification TestingThe New England Journal of Medicine, 2004